New Brunswick Scientific (www.nbsc.com) has incorporated Allen Bradley PLC controls into its BioFlo Pro fermentors and bioreactors for system regulation, as well as easy exchange of data with auxiliary bioprocessing systems.
New Brunswick Scientific (www.nbsc.com) has incorporated Allen Bradley PLC controls into its BioFlo Pro fermentors and bioreactors for system regulation, as well as easy exchange of data with auxiliary bioprocessing systems. The 75–3,000 L BioFlo Pro fermentors and bioreactors for R&D through GMP production use modular components for rapid delivery and ready customization at any time. Integration of Allen Bradley Control Logix Process Controller provides a variety of benefits ranging from rapid response for system control, to the ability to transmit both an alarm signal, as well as details of the alarm condition to manufacturing supervisory systems. NBS BioFlo Pro fermentors and bioreactors feature a small footprint to minimize space requirements and open piping frame with plenty of space between valves for easy access during operation and maintenance.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
May 14th 2025Imagine a world where cleanroom facilities—essential for pharmaceutical manufacturing, biotechnology, and high-tech industries—are built with unparalleled speed, precision, and efficiency. That world is here, thanks to the hybrid construction approach. By blending traditional stick-built methods with modular and prefabricated solutions, companies are overcoming the limitations of conventional construction while ensuring compliance with stringent industry regulations. In this interview, we explore how hybrid cleanroom construction is transforming the industry, offering faster project timelines, improved quality control, and significant cost advantages. Join us as we delve into this game-changing approach with industry experts who are leading the charge in revolutionizing cleanroom infrastructure.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.